September 2, 2026 – Fellowship-trained neuro-oncologist Nishika Karbhari, M.D., has joined Baptist Health Herbert Wertheim Cancer Institute. She specializes in the treatment of primary and metastatic brain and spinal cord tumors, with clinical interests in personalized treatment planning, novel therapeutics and clinical research aimed at advancing care for patients with neurologic cancers. Her research interests include gliomas, brain tumor biology, immunotherapy, genomics and emerging treatment approaches in neuro-oncology.

Prior to joining Baptist Health, Dr. Karbhari completed a neuro-oncology fellowship at Mayo Clinic in Rochester, Minnesota. She previously completed an internal medicine internship and neurology residency at Dartmouth Health in Lebanon, New Hampshire, serving as academic chief resident during her final year.

“We are pleased to welcome Dr. Karbhari to Baptist Health,” said Leonard Kalman, M.D., acting system chief executive, Baptist Health Cancer Care, and acting executive medical director, Herbert Wertheim Cancer Institute. “Her expertise in neuro-oncology, dedication to research and commitment to compassionate, patient-centered care will further strengthen our multidisciplinary program for patients with brain and spinal cord tumors.”

Dr. Karbhari earned her medical degree with Distinction in Research from The University of Texas Southwestern Medical Center. She is certified by the American Board of Psychiatry and Neurology in adult neurology and by the United Council for Neurologic Subspecialties in neuro-oncology.

Dr. Karbhari has authored numerous peer-reviewed publications and presented her research at national scientific meetings. Throughout her training, she received multiple awards recognizing excellence in research and clinical performance, including Dartmouth Health’s Top Resident Award and Murray B. Bornstein Research Award.

Dr. Karbhari believes in a collaborative approach to care, partnering closely with patients, their families and a multidisciplinary team to develop individualized treatment plans.

“I am committed to ensuring every patient feels informed, supported and empowered throughout their treatment journey,” Dr. Karbhari said. “By combining the latest scientific evidence with compassionate, personalized care, my goal is to help patients achieve the best possible outcomes while maintaining their quality of life.”

Outside of medicine, Dr. Karbhari enjoys running, spending time outdoors and exploring new places with her cat. She will see patients at Baptist Health Herbert Wertheim Cancer Institute, 8900 N. Kendall Drive, Miami.

About Baptist Health

Baptist Health is the largest healthcare organization in the region, with 12 hospitals, more than 30,000 employees, 4,500 physicians and 200 outpatient centers, urgent care facilities and physician practices spanning across Miami-Dade, Monroe, Broward and Palm Beach counties. Baptist Health has internationally renowned institutes specializing in cancer care, brain and spine care, heart and vascular care and orthopedic care. In addition, it includes Baptist Health Medical Group; Baptist Health Quality Network; and The Baptist Health PineApp, a virtual health platform. Baptist Health South Florida is an academic and clinical affiliate of Florida International University Herbert Wertheim College of Medicine.  A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Baptist Health has been recognized by Fortune as one of the 100 Best Companies to Work For in America and is the most awarded healthcare system in South Florida by U.S. News and World Report. For more information, visit BaptistHealth.net/Newsroom and connect with us on Facebook, X, Instagram, TikTok and LinkedIn.